<div>
  <ul>
    <li>
      <p>
        Telepsychiatry platform provider LifeStance released its FY 2022 earnings, indicating a loss per share of USD 0.61, meeting average analyst expectations of USD 0.6. Net losses for the period shrunk to USD 216 million from USD 307 million in FY 2021 representing a 30% YoY reduction.
      </p>
    </li>
    <li>
      <p>
        The company achieved revenues of USD 860 million for the period, implying a 29% YoY growth. This was attributed to an increase in user visits throughout the year. Additionally, the company increased its total clinician base on its platform by 841 clinicians during the period, representing an 18% YoY growth in clinicians. During the period, the company also opened 90 new centers to bolster its hybrid virtual/in-person care model and expanded its presence across the US to a total of nine states. Talkspace also carried out 13 acquisitions during the year, bringing the total acquisitions since the company&rsquo;s inception to 90.&nbsp;
      </p>
    </li>
    <li>
      <p>
        The adjusted EBITDA increased 7% YoY to USD 53 million, but margins contracted to 6.1% for FY2022 compared to 7.4% in FY 2021. The drop in margins was due to higher-than-expected general and administrative expenses incurred during the period, caused by accelerated investments in the company.&nbsp;
      </p>
    </li>
    <li>
      <p>
        For FY 2023, the company expects to earn full-year revenues between USD 980 million and USD 1,020 million (representing a YoY growth between 14%&ndash;19%) and expects Adjusted EBITDA between USD 50 million and USD 62 million (representing a YoY change between -5%&ndash;18%).
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://investor.lifestance.com/news-releases/news-release-details/lifestance-reports-fourth-quarter-and-full-year-2022-results">
      Company press release
    </a>
  </p>
</div>


All Updates

LifeStance Health releases FY 2022 results, meets analyst expectations

Lifestance health releases Q3 2022 earnings, revises guidance downward

LifeStance releases Q2 2022 earnings; reaffirms 2022 guidance toward lower band

LifeStance releases earnings for Q1 2022 and reaffirms guidance for 2022